BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6761080)

  • 1. Pharmacokinetics and antibacterial efficacy in vivo of beta-lactam combinations against Proteus vulgaris.
    Dalhoff A; Gehl AE; Gau W; Lode H
    Chemotherapy; 1982; 28(6):444-53. PubMed ID: 6761080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic in vitro studies of antibacterial effects of the combination of new penicillins and cefalosporins against Proteus vulgaris.
    Dalhoff A; Gehl AE; Lode H
    Chemotherapy; 1982; 28(5):381-9. PubMed ID: 6754281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of mezlocillin and cefoxitin against Proteus morganii in the granuloma pouch model.
    Dalhoff A
    Eur J Clin Microbiol; 1982 Aug; 1(4):243-7. PubMed ID: 6217067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mode of interaction between immunoglobulin G and mezlocillin against beta-lactamase producing bacteria.
    Dalhoff A; Brunner H
    Arzneimittelforschung; 1983; 33(12):1666-71. PubMed ID: 6607736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of inducible cephalosporinase remaining in the experimentally infected rat granuloma pouch after beta-lactam therapy.
    Araki H; Minami S; Watanabe Y; Yasuda T
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1131-6. PubMed ID: 1929254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in vitro activities of eight new beta-lactam compounds against cephalothin-resistant Enterobacteriaceae from hospital patients.
    Costopoulos C; Legakis NJ; Papafragas E; Marinis E
    Chemotherapy; 1984; 30(3):158-64. PubMed ID: 6610538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducer activity of beta-lactam antibiotics for the beta-lactamases of Proteus rettgeri and Proteus vulgaris.
    Yotsuji A; Minami S; Araki Y; Inoue M; Mitsuhashi S
    J Antibiot (Tokyo); 1982 Nov; 35(11):1590-3. PubMed ID: 6761329
    [No Abstract]   [Full Text] [Related]  

  • 8. Paradoxical antibacterial activities of beta-lactams against Proteus vulgaris: mechanism of the paradoxical effect.
    Ikeda Y; Nishino T
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1073-7. PubMed ID: 3056246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial antagonism of beta-lactam antibiotics in experimental infections.
    Kasai K
    Chemotherapy; 1986; 32(2):148-58. PubMed ID: 3516593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effect of SF-2103A, a novel carbapenem antibiotic, in combination with cefotaxime, cefoperazone and other cephalosporins.
    Yoshida T; Kazuno Y; Shomura T; Murata S; Inouye S; Ito T
    J Antibiot (Tokyo); 1986 Jul; 39(7):956-65. PubMed ID: 3531130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Induction of beta-lactamases in Enterobacter cloacae with beta-lactam antibiotics].
    Cullmann W; Dick W
    Immun Infekt; 1984 Feb; 12(1):29-34. PubMed ID: 6335880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the synergism of sulbactam and beta-lactam antibiotics under in vitro conditions and in healthy volunteers after intravenous administration. Antibacterial activity in vitro, compatibility and pharmacokinetics of the drugs in combination.
    Wildfeuer A; Schmalreck A; Räder K; Eibel G; Pfaff G
    Arzneimittelforschung; 1989 Jan; 39(1):94-100. PubMed ID: 2785802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical antibacterial activity of cefmenoxime against Proteus vulgaris.
    Ikeda Y; Nishino T; Tanino T
    Antimicrob Agents Chemother; 1987 Jun; 31(6):865-9. PubMed ID: 3304155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergy between acylureidopenicillins and immunoglobulin G in experimental animals.
    Dalhoff A
    Am J Med; 1984 Mar; 76(3A):91-100. PubMed ID: 6424463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.
    Martín MA; Castillo AM; Liébana J; Marín A; Alados JC; Piédrola G
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):189-97. PubMed ID: 1940333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of beta-lactamase induction in Pseudomonas aeruginosa.
    Dalhoff A; Cullmann W
    J Antimicrob Chemother; 1984 Oct; 14(4):349-57. PubMed ID: 6438044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical activity of beta-lactam antibiotics against Proteus vulgaris in experimental infection in mice.
    Ikeda Y; Fukuoka Y; Motomura K; Yasuda T; Nishino T
    Antimicrob Agents Chemother; 1990 Jan; 34(1):94-7. PubMed ID: 2183712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro microbiological properties of mezlocillin compared with four cephalosporins.
    Esposito S; Galante D; Barba D
    Chemioterapia; 1986 Aug; 5(4):273-7. PubMed ID: 3490314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
    Schmalreck AF; Wildfeuer A
    Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of beta-lactamase in Proteus vulgaris.
    Okonogi K; Kuno M; Higashide E
    J Gen Microbiol; 1986 Jan; 132(1):143-50. PubMed ID: 3519851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.